ECSP11011497A - Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos - Google Patents

Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos

Info

Publication number
ECSP11011497A
ECSP11011497A ECSP11011497A ECSP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A EC SP11011497 A ECSP11011497 A EC SP11011497A
Authority
EC
Ecuador
Prior art keywords
fatty acids
metabolism
radiotrazers
imagimatics
conservation
Prior art date
Application number
Other languages
English (en)
Inventor
Robert H Mach
Robert John Gropler
Zhude Tu
Pilar Herrero
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of ECSP11011497A publication Critical patent/ECSP11011497A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen moléculas del análogo de ácido graso (FAA) que comprenden radionúclidos, de emisión de positrones, sales de éstos, y FAA-triglicéridos. Se describen, además, los métodos de síntesis, y métodos de distribución de imágenes y metabolismo de los ácidos grasos y triglicéridos de ácidos grasos.
ECSP11011497 2009-05-04 2011-12-01 Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos ECSP11011497A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17506509P 2009-05-04 2009-05-04

Publications (1)

Publication Number Publication Date
ECSP11011497A true ECSP11011497A (es) 2012-03-30

Family

ID=43050827

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP11011497 ECSP11011497A (es) 2009-05-04 2011-12-01 Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos

Country Status (19)

Country Link
US (1) US20120100073A1 (es)
EP (1) EP2427218A4 (es)
JP (1) JP2012526129A (es)
KR (1) KR20120060943A (es)
CN (1) CN102421454A (es)
AU (1) AU2010246010A1 (es)
BR (1) BRPI1014538A2 (es)
CA (1) CA2760334A1 (es)
CL (1) CL2011002753A1 (es)
CO (1) CO6460756A2 (es)
CR (1) CR20110637A (es)
EA (1) EA201171355A1 (es)
EC (1) ECSP11011497A (es)
IL (1) IL216124A0 (es)
MX (1) MX2011011743A (es)
NO (1) NO20111663A1 (es)
SG (1) SG175430A1 (es)
WO (1) WO2010129572A2 (es)
ZA (1) ZA201108053B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021369D0 (en) * 2010-12-16 2011-01-26 Ge Healthcare Ltd Radioiodinated fatty acids
JP6352188B2 (ja) 2012-08-20 2018-07-04 大塚製薬株式会社 糖代謝能の測定方法及びそれに使用する組成物
WO2014142248A1 (ja) * 2013-03-15 2014-09-18 大塚製薬株式会社 脂肪酸燃焼によるインスリン抵抗性の測定方法、並びにそれに使用する組成物
WO2015023631A2 (en) * 2013-08-12 2015-02-19 Carolyn Anderson Fatty acid analogs and their use
WO2016178852A1 (en) 2015-05-04 2016-11-10 The Trustees Of The University Of Pennsylvania 211-astatine containing radiotherapeutics for the treatment of cancer
CA3106903A1 (en) 2018-07-20 2020-01-23 Astellas Pharma Inc. Fatty acid derivative labeled with positron-emitting radionuclide
WO2021145403A1 (ja) * 2020-01-17 2021-07-22 アステラス製薬株式会社 陽電子放出核種で標識された脂肪酸誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2846491A (en) * 1955-12-13 1958-08-05 Air Reduction Reactions of sodium acetylide with alkyl halides
EP0136879A3 (en) * 1983-09-30 1987-01-07 Yamanouchi Pharmaceutical Co., Ltd. Fatty acid derivatives and processes of producing them
DE68901781T2 (de) * 1988-02-03 1993-01-07 Univ Washington Enzymsubstrate auf der basis neuer fettsaeureanaloge.
ATE139524T1 (de) * 1990-10-12 1996-07-15 Univ Washington Azido-substituierte fettsäuren als enzymsubstratanaloge
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
US5747537A (en) * 1995-09-05 1998-05-05 Washington University Method of inhibiting parasitic activity
CA2238860C (en) * 1995-12-01 2009-01-13 David R. Elmaleh Stereoisomers of fatty acid analogs for diagnostic imaging
BR0307409A (pt) * 2002-02-01 2004-12-28 Dainippon Pharmaceutical Co Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
EP1622602B1 (en) * 2003-04-17 2008-08-20 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
CN101913973B (zh) * 2003-07-24 2013-11-20 皇后医学中心 烷基化剂的制备和用途
JP4455413B2 (ja) * 2004-06-11 2010-04-21 キヤノン株式会社 ビニル基、エステル基、カルボキシル基並びにスルホン酸基を有するポリヒドロキシアルカン酸並びにその製造方法

Also Published As

Publication number Publication date
NO20111663A1 (no) 2011-12-02
CL2011002753A1 (es) 2012-07-13
EA201171355A1 (ru) 2012-05-30
IL216124A0 (en) 2012-01-31
EP2427218A2 (en) 2012-03-14
BRPI1014538A2 (pt) 2016-04-05
WO2010129572A3 (en) 2010-12-29
CN102421454A (zh) 2012-04-18
ZA201108053B (en) 2012-07-25
AU2010246010A1 (en) 2011-11-17
MX2011011743A (es) 2011-11-29
EP2427218A4 (en) 2014-06-18
KR20120060943A (ko) 2012-06-12
CR20110637A (es) 2012-02-09
WO2010129572A2 (en) 2010-11-11
CO6460756A2 (es) 2012-06-15
US20120100073A1 (en) 2012-04-26
SG175430A1 (en) 2011-12-29
CA2760334A1 (en) 2010-11-11
JP2012526129A (ja) 2012-10-25

Similar Documents

Publication Publication Date Title
ECSP11011497A (es) Radiotrazadores pet para la imagimática del metabolismo y conservación de ácidos grasos
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
CU20190058A7 (es) Composiciones de aminoácidos relacionadas con mejoras de la función hepática
CL2014000183A1 (es) Formulación farmacéutica que contienen anticuerpos anti-pcsk9; metodo para preparar dicha formulación.
AR085507A1 (es) Animales modificados geneticamente y metodos para su obtencion
BR112012023876A2 (pt) aperfeiçoamentos em ou referentes a resfriamento
ECSP13012715A (es) Método para producir preparados farmacéuticos con contenido de ibp
ES2643848T3 (es) Método para cuantificar dosis UV desinfectantes usando indicadores
UY32037A (es) Daa-piridina
BR112012018131A2 (pt) aparelho, servidor, método e sistema de agrupamento de produto, e, meio de gravação
CL2013001604A1 (es) Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis.
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CU20120162A7 (es) Colorantes de perileno enlazados a polímero y composiciones que los contienen
ES2596248T3 (es) N-Carbamoilputrescina para mejorar la síntesis de proteínas musculares
CL2014000315A1 (es) Proceso que sirve para medir cantidad de enzima digestiva liberada por composición en un medio que comprende usar espectroscopia de fluorescencia.
BR112013015634B8 (pt) composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição
ES2508165T3 (es) Lactoferrina y sustancia blanca
BR112012016054A2 (pt) Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
AR070320A1 (es) Metodos para alimentar cerdos y productos que comprenden acidos grasos beneficos
UY35856A (es) Producción de acidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio.
BR112015030135A2 (pt) ésteres de ácidos oligo-hidróxi carboxílicos e seu uso
CL2016002362A1 (es) Composiciones semioquímicas para reducir conflictos sociales con gatos.
AR092423A1 (es) Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas
BR112014008527A2 (pt) núcleo absorvente
CL2011000621A1 (es) Agente que contiene por lo menos un acido acilciclohexanodionacarboxilico y/o sus sales en combinacion con por lo menos un ester de acido acilciclohexanodionacarboxilico y su uso para mejorar el desarrollo de gramineas.